Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?
Biomolecules · 11.02.2023 · 13 (2) · 353
DOI: 10.3390/biom13020353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 11.02.2023. Verfasst von Ruolei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Cancer Research, Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Neoplasms. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Japan AMED.
Abstract (Originalsprache)
The imbalance between reactive oxygen species (ROS) production and clearance causes oxidative stress and ROS, which play a central role in regulating cell and tissue physiology and pathology. Contingent upon concentration, ROS influence cancer development in contradictory ways, either stimulating cancer survival and growth or causing cell death. Cells developed evolutionarily conserved programs to sense and adapt redox the fluctuations to regulate ROS as either signaling molecules or toxic insults. The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2)-KEAP1 system is the master regulator of cellular redox and metabolic homeostasis. NRF2 has Janus-like roles in carcinogenesis and cancer development. Short-term NRF2 activation suppresses tissue injury, inflammation, and cancer initiation. However, cancer cells often exhibit constitutive NRF2 activation due to genetic mutations or oncogenic signaling, conferring advantages for cancer cells’ survival and growth. Emerging evidence suggests that NRF2 hyperactivation, as an adaptive cancer phenotype under stressful tumor environments, regulates all hallmarks of cancer. In this review, we summarized the source of ROS, regulation of ROS signaling, and cellular sensors for ROS and oxygen (O2), we reviewed recent progress on the regulation of ROS generation and NRF2 signaling with a focus on the new functions of NRF2 in cancer development that reach beyond what we originally envisioned, including regulation of cancer metabolism, autophagy, macropinocytosis, unfolded protein response, proteostasis, and circadian rhythm, which, together with anti-oxidant and drug detoxification enzymes, contributes to cancer development, metastasis, and anticancer therapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Center for Cancer Research, Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
ORCID-Profile: Kazumi Iwata, Feng He
Förderung
- National Natural Science Foundation of China
- Japan AMED
Zitieren
APA
Wang, R., Liang, L., Matsumoto, M., Iwata, K., Umemura, A., & He, F. (2023). Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?. Biomolecules, 13(2), 353. https://doi.org/10.3390/biom13020353
Vancouver
Wang R, Liang L, Matsumoto M, Iwata K, Umemura A, He F. Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?. Biomolecules. 2023;13(2):353. doi:10.3390/biom13020353
BibTeX
@article{Wang2023,
author = {Wang, Ruolei and Liang, Lirong and Matsumoto, Misaki and Iwata, Kazumi and Umemura, Atsushi and He, Feng},
title = {Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {2},
pages = {353},
doi = {10.3390/biom13020353}
}
EUVIMED